chitosan has been researched along with calcitonin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 16 (66.67) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Sinswat, P; Tengamnuay, P | 1 |
| Bernkop-Schnürch, A; Guggi, D; Kast, CE | 1 |
| Wang, ZY; Zhang, Q | 1 |
| Hinchcliffe, M; Jabbal-Gill, I; Smith, A | 1 |
| Alonso, MJ; Fernandez-Megia, E; Novoa-Carballal, R; Prego, C; Quiñoá, E; Torres, D | 1 |
| Alonso, MJ; Fabre, M; Prego, C; Torres, D | 1 |
| Chen, JY; Fan, HS; Li, DX; Lu, J; Tan, YF; Xiao, WQ; Xiao, YM; Zhang, XD; Zhu, XD | 1 |
| du Plessis, LH; Kotzé, AF; Lubbe, J; Strauss, T | 1 |
| Makhlof, A; Takeuchi, H; Tozuka, Y; Werle, M | 1 |
| Huang, A; Makhlof, A; Ping, Q; Takeuchi, H; Tozuka, Y | 1 |
| Schwendeman, SP; Zhang, Y | 1 |
| Kawashima, Y; Kurashima, H; Takeuchi, H; Tsujimoto, H; Yamamoto, H; Yang, M; Yokoyama, T | 1 |
| Brayden, DJ; Corrigan, OI; Kornerup, KN; McMorrow, J; Murphy, EP; Patel, HB; Perretti, M; Ryan, SM; Tajber, L; Umerska, A | 1 |
| Chatchawalsaisin, J; Kulvanich, P; Sinsuebpol, C | 1 |
| Almer, G; Barthelmes, J; Bernkop-Schnürch, A; Dünnhaupt, S; Fröhlich, E; Gradauer, K; Mangge, H; Prassl, R; Roblegg, E; Teubl, B; Vonach, C | 1 |
| Deng, Y; Huang, A; Li, S; Ping, Q; Su, Z; Sun, M; Xiao, Y | 1 |
| Alhalaweh, A; Cha, KH; Cho, W; Hwang, SJ; Jung, MS; Kim, JS; Kim, MS; Park, HJ; Park, J; Velaga, SP | 1 |
| Corrigan, OI; Tajber, L; Umerska, A | 2 |
| Onishi, H; Tokuyasu, A | 1 |
| Choonara, YE; du Toit, LC; Govender, M; Hibbins, AR; Indermun, S; Kumar, P; Pillay, V | 1 |
| Brama, PAJ; Brayden, DJ; Crean, D; Fawcett, K; Kearney, C; Labberte, MC; Leggett, B; Sladek, S; Tajber, L | 1 |
| Gao, JQ; Liu, L; Lou, Y; Lu, XY; Miao, J; Wu, JY; Yang, H | 1 |
| Chen, Y; He, S; Le, Z; Leong, KW; Liu, J; Liu, L; Liu, Z; Mao, HQ; Sun, L | 1 |
24 other study(ies) available for chitosan and calcitonin
| Article | Year |
|---|---|
Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Absorption; Animals; beta-Cyclodextrins; Biological Availability; Calcitonin; Chitin; Chitosan; Cyclodextrins; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Nasal Mucosa; Rats; Rats, Sprague-Dawley | 2003 |
In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix.
Topics: Animals; Biological Availability; Calcitonin; Chemistry, Pharmaceutical; Chitin; Chitosan; Drug Carriers; Drug Delivery Systems; Excipients; Glutathione; Male; Rats; Rats, Wistar; Solubility; Tablets; Trypsin Inhibitor, Bowman-Birk Soybean | 2003 |
[Study on pulmonary delivery of peptide drugs in rats: effects of absorption enhancers on cellular membrane fluidity].
Topics: Absorption; Animals; Biological Availability; Calcitonin; Caprylates; Cell Membrane; Chitin; Chitosan; Drug Synergism; Lung; Male; Membrane Fluidity; Membrane Proteins; Molecular Conformation; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Sodium Cholate | 2003 |
Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep.
Topics: Adjuvants, Pharmaceutic; Administration, Intranasal; Animals; Biological Availability; Calcitonin; Chitosan; Cross-Over Studies; Enzyme-Linked Immunosorbent Assay; Male; Nasal Mucosa; Sheep | 2005 |
Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.
Topics: Administration, Oral; Animals; Caco-2 Cells; Calcitonin; Calcium; Capsules; Cell Survival; Chitosan; Drug Carriers; Humans; Intestinal Absorption; Male; Nanoparticles; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Solubility | 2006 |
Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery.
Topics: Administration, Oral; Animals; Caco-2 Cells; Calcitonin; Calcium; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; HT29 Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Male; Mucus; Nanostructures; Peptides; Rats; Rats, Sprague-Dawley; Solubility | 2006 |
Controllable release of salmon-calcitonin in injectable calcium phosphate cement modified by chitosan oligosaccharide and collagen polypeptide.
Topics: Animals; Bone Regeneration; Calcitonin; Calcium Phosphates; Cementation; Chemical Precipitation; Chitosan; Collagen; Compressive Strength; Delayed-Action Preparations; Drug Carriers; Injections; Materials Testing; Oligosaccharides; Peptides; Rats; Time Factors | 2007 |
Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
Topics: Administration, Intranasal; Administration, Oral; Animals; Calcitonin; Chemistry, Pharmaceutical; Chitosan; Colloids; Dosage Forms; Drug Carriers; Fatty Acids; Intestinal Absorption; Jejunum; Liposomes; Male; Particle Size; Rats; Rats, Sprague-Dawley; Technology, Pharmaceutical | 2010 |
Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin.
Topics: Absorption; Animals; Bone Density Conservation Agents; Calcitonin; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Lung; Male; Nanoparticles; Nanotechnology; Particle Size; Rats; Thioglycolates | 2010 |
N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin.
Topics: Administration, Oral; Animals; Blood; Bone Density Conservation Agents; Calcitonin; Calcium; Chitosan; Cholesterol; Coumarins; Drug Carriers; Hydrogen-Ion Concentration; Intestine, Small; Magnetic Resonance Spectroscopy; Male; Microscopy, Atomic Force; Mucins; Organophosphates; Particle Size; Phosphatidylcholines; Rats; Rats, Wistar; Static Electricity; Surface Properties; Thiazoles; Unilamellar Liposomes | 2011 |
Minimizing acylation of peptides in PLGA microspheres.
Topics: Acylation; Animals; Calcitonin; Cations, Divalent; Chitosan; Drug Carriers; Drug Stability; Excipients; Glucose; Humans; Lactic Acid; Octreotide; Parathyroid Hormone; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Salts | 2012 |
Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles.
Topics: Absorption; Administration, Inhalation; Animals; Calcitonin; Chemistry, Pharmaceutical; Chitosan; Hypocalcemia; Lactic Acid; Lung; Male; Nanocomposites; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Powders; Rats; Rats, Wistar; Technology, Pharmaceutical | 2012 |
An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Calcitonin; Cell Line; Cell Line, Tumor; Chitosan; Cyclic AMP; Humans; Hyaluronic Acid; Matrix Metalloproteinase 13; Mice; Nanoparticles; Nuclear Receptor Subfamily 4, Group A, Member 2; RNA, Messenger | 2013 |
Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
Topics: Administration, Inhalation; Animals; Bone Density Conservation Agents; Calcitonin; Chitosan; Drug Compounding; Drug Delivery Systems; Lung; Male; Mannitol; Nanoparticles; Particle Size; Powders; Rats; Rats, Sprague-Dawley; Temperature | 2013 |
Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats.
Topics: Administration, Oral; Animals; Calcitonin; Chitosan; Intestine, Small; Liposomes; Male; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds | 2013 |
Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Topics: Administration, Oral; Animals; Arginine; Caco-2 Cells; Calcitonin; Cell Line, Tumor; Chitosan; Dextrans; Drug Carriers; Fluorescein-5-isothiocyanate; Humans; Intestinal Absorption; Intestinal Mucosa; Liposomes; Permeability; Rats; Rats, Sprague-Dawley | 2014 |
Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
Topics: Administration, Intranasal; Animals; Biological Availability; Calcitonin; Carbon Dioxide; Chitosan; Desiccation; Drug Compounding; Inulin; Male; Powders; Rats, Sprague-Dawley; Trehalose | 2015 |
Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
Topics: Calcitonin; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Drug Storage; Hyaluronic Acid; Hydrophobic and Hydrophilic Interactions; Molecular Weight; Nanoparticles; Particle Size; Peptides; Solubility; Spectroscopy, Fourier Transform Infrared; Static Electricity; Time Factors; Viscosity | 2014 |
Preparation and Evaluation of Enteric-Coated Chitosan Derivative-Based Microparticles Loaded with Salmon Calcitonin as an Oral Delivery System.
Topics: Administration, Oral; Animals; Bone Density Conservation Agents; Calcitonin; Calcium; Chitosan; Drug Delivery Systems; Microspheres; Molecular Structure; Particle Size; Rats | 2016 |
Design of chondroitin sulfate-based polyelectrolyte nanoplexes: Formation of nanocarriers with chitosan and a case study of salmon calcitonin.
Topics: Calcitonin; Chitosan; Chondroitin Sulfates; Hydrogen-Ion Concentration; Nanoparticles; Particle Size; Polyelectrolytes | 2017 |
In Vitro-In Vivo Evaluation of an Oral Ghost Drug Delivery Device for the Delivery of Salmon Calcitonin.
Topics: Administration, Oral; Animals; Calcitonin; Calcium-Regulating Hormones and Agents; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Equipment Design; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections, Intramuscular; Swine | 2018 |
Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation.
Topics: Animals; Arthrocentesis; Biomarkers; Calcitonin; Chitosan; Disease Models, Animal; Drug Carriers; Horses; Hyaluronic Acid; Injections, Intra-Articular; Lipopolysaccharides; Nanoconjugates; Pilot Projects; Synovial Fluid; Synovitis | 2018 |
Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Calcitonin; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Humans; Intestinal Absorption; Intestinal Secretions; Isoflavones; Nanoparticles; Rats, Sprague-Dawley | 2019 |
Flash Fabrication of Orally Targeted Nanocomplexes for Improved Transport of Salmon Calcitonin across the Intestine.
Topics: Administration, Oral; Animals; Biological Availability; Biological Transport; Caco-2 Cells; Calcitonin; Calcium; Calcium-Regulating Hormones and Agents; Chitosan; Dextran Sulfate; Drug Delivery Systems; Drug Liberation; Drug Stability; Half-Life; Humans; Hypocalcemia; Injections, Subcutaneous; Intestinal Absorption; Male; Nanocomposites; Rats; Rats, Sprague-Dawley; Taurocholic Acid | 2020 |